Literature DB >> 11421540

Pheochromocytoma: clinical observations from a Brooklyn tertiary hospital.

M Ariton1, C S Juan, T W AvRuskin.   

Abstract

OBJECTIVE: To report eight cases of pheochromocytoma, diagnosed and treated at our tertiary hospital during a 42-month period.
METHODS: We review clinical manifestations as well as historical and family data. Biochemical and radiologic methods for diagnosis and tumor localization at our institution were compared with methods at other teaching centers.
RESULTS: Among 4,180 patients with essential hypertension encountered during a 42-month interval, 8 had pheochromocytoma. The most common clinical findings were diaphoresis, chest or abdominal pain, palpitations, headaches, and nausea. Clinical features were remarkable only for the significant correlation between urinary excretion of vanillylmandelic acid and tumor volume (r = 0.925; P<0.01). Only one patient, with a history of medullary thyroid carcinoma, had multiple endocrine neoplasia. No unusual familial concentration of pheochromocytomas was found in our community, and our diagnostic techniques were similar to those reported from other institutions. We calculated an average annual incidence rate of 0.5 per 100,000 person-years, a figure comparable to that reported at the Mayo Clinic in Rochester, Minnesota.
CONCLUSION: Because our institution does not see the volume of referral patients as does the Mayo Clinic, we suggest that the frequency of pheochromocytoma may be underestimated in the patient population that we serve.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11421540     DOI: 10.4158/EP.6.3.249

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  20 in total

Review 1.  Accuracy of recommended sampling and assay methods for the determination of plasma-free and urinary fractionated metanephrines in the diagnosis of pheochromocytoma and paraganglioma: a systematic review.

Authors:  Roland Därr; Matthias Kuhn; Christoph Bode; Stefan R Bornstein; Karel Pacak; Jacques W M Lenders; Graeme Eisenhofer
Journal:  Endocrine       Date:  2017-04-12       Impact factor: 3.633

2.  Hypertension in pheochromocytoma: characteristics and treatment.

Authors:  Samuel M Zuber; Vitaly Kantorovich; Karel Pacak
Journal:  Endocrinol Metab Clin North Am       Date:  2011-06       Impact factor: 4.741

Review 3.  Secondary Arterial Hypertension: From Routine Clinical Practice to Evidence in Patients with Adrenal Tumor.

Authors:  Marco Grasso; Marco Boscaro; Carla Scaroni; Filippo Ceccato
Journal:  High Blood Press Cardiovasc Prev       Date:  2018-11-10

4.  Bronchial Paraganglioma with SDHB Deficiency.

Authors:  M R Ghigna; P Dorfmuller; A Crutu; E Fadel; V Thomas de Montpréville
Journal:  Endocr Pathol       Date:  2016-12       Impact factor: 3.943

Review 5.  Screening for pheochromocytomas and paragangliomas.

Authors:  Graeme Eisenhofer
Journal:  Curr Hypertens Rep       Date:  2012-04       Impact factor: 5.369

Review 6.  Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management.

Authors:  Graeme Eisenhofer; Graham Rivers; Alejandro L Rosas; Zena Quezado; William M Manger; Karel Pacak
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 7.  Adrenal causes of hypertension: pheochromocytoma and primary aldosteronism.

Authors:  William F Young
Journal:  Rev Endocr Metab Disord       Date:  2007-12       Impact factor: 6.514

8.  Fever of Unknown Origin: Could It Be a Pheochromocytoma? A Case Report and Review of the Literature.

Authors:  Uzma Mohammad Siddiqui; Stephany Matta; Mireya A Wessolossky; Richard Haas
Journal:  Case Rep Endocrinol       Date:  2018-07-03

9.  Endocrine hypertension: An overview on the current etiopathogenesis and management options.

Authors:  Reena M Thomas; Ewa Ruel; Prapimporn Ch Shantavasinkul; Leonor Corsino
Journal:  World J Hypertens       Date:  2015

10.  Evaluating the optimum rest period prior to blood collection for fractionated plasma free metanephrines analysis.

Authors:  T P Griffin; R Casey; D Wall; M Bell; P M O'Shea
Journal:  Pract Lab Med       Date:  2016-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.